ASTHMA & ALLERGIC DISEASE CENTER FOR IMMUNODERMATOLOGY
哮喘
基本信息
- 批准号:3105055
- 负责人:
- 金额:$ 17.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-09-01 至 1986-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Support is requested for the establishment and maintenance of a
multidisciplinary center for the study of immunologic mechanisms which may
play a role in the pathogenesis of certain cutaneous diseases. Such a
center will harness the combined efforts of dermatologists, immunologists
and allergists from various departments in the University of California,
San Diego. This application is directed to three areas of research
relevant to skin diseases: (a) Immunoregulatory mechanisms in patients
with a variety of skin diseases thought to be immunologic in nature, (b)
metabolic and biochemical alterations in immunologically damaged skin and
(c) regulation of cell traffic in the epidermis and relation to the
Langerhans cell.
Because of their prevalence and relevance, the specific diseases to be
studied include leukocytoclastic vasculitis, drug eruptions, urticaria and
atopic dermatitis.
Cutaneous phototoxic reactions mediated either by drugs or by endogenous
phototoxic chemicals (prophyrias) offer excellent models to study tissue
damage produced by activation of the complement system and the subsequent
release of chemical mediators. The question of whether Langerhans cells
have a "trophic" function for lymphoid cells will be investigated. Its
role in vivo will be evaluated by assessing its involvement in a variety of
skin diseases in which a cell-mediated immunologic mechanism seems to be
involved. These studies may help not only to further our knowledge in this
area, but will serve in the development of new therapeutic approaches.
要求建立和维护
免疫机制研究的多学科研究中心
在某些皮肤病的发病机理中发挥作用。 这样的
中心将利用皮肤科医生,免疫学家的综合努力
以及来自加利福尼亚大学各个系的过敏症分子
圣地亚哥。 该应用程序针对三个研究领域
与皮肤疾病有关:(a)患者的免疫调节机制
具有多种皮肤疾病本质上是免疫学的,(b)
免疫学损害皮肤的代谢和生化改变和生化改变
(c)调节表皮中的细胞流量和与
Langerhans细胞。
由于其流行和相关性,特定疾病是
所研究的包括白细胞碎屑血管炎,药物喷发,荨麻疹和
特应性皮炎。
皮肤光毒反应由药物或内源性介导
光毒性化学物质(预言)为研究组织提供了出色的模型
补体系统激活和随后的损害
化学介质的释放。 Langerhans是否细胞的问题
将研究具有淋巴样细胞的“营养”功能。 它是
在体内的角色将通过评估其参与多种
细胞介导的免疫机制的皮肤疾病似乎是
涉及。 这些研究不仅可以帮助我们进一步了解这一点
区域,但将用于开发新的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRMA GIGLI其他文献
IRMA GIGLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRMA GIGLI', 18)}}的其他基金
相似海外基金
Characterization of degranulation regulators in human mast cells
人类肥大细胞脱颗粒调节剂的表征
- 批准号:
10284390 - 财政年份:2021
- 资助金额:
$ 17.46万 - 项目类别:
Experimental and Computational Analysis of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) Cohort
人类流行病学和对 SARS-CoV-2 (HEROS) 队列反应的实验和计算分析
- 批准号:
10290261 - 财政年份:2021
- 资助金额:
$ 17.46万 - 项目类别:
Functional role of miR-511-3p in allergic asthma and its underlying mechanisms
miR-511-3p在过敏性哮喘中的功能作用及其潜在机制
- 批准号:
10385822 - 财政年份:2021
- 资助金额:
$ 17.46万 - 项目类别:
Foxp3DEx2 isoform expression leads to Treg dysfunction and SLE
Foxp3DEx2 同工型表达导致 Treg 功能障碍和 SLE
- 批准号:
10363690 - 财政年份:2021
- 资助金额:
$ 17.46万 - 项目类别:
Functional role of miR-511-3p in allergic asthma and its underlying mechanisms
miR-511-3p在过敏性哮喘中的功能作用及其潜在机制
- 批准号:
10210838 - 财政年份:2021
- 资助金额:
$ 17.46万 - 项目类别: